ALXN1830

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALXN1830, covering 2024-03-22 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ALXN1830 in Healthy Adult Participants [Phase 1]